Preclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies.
Puttemans J, Dekempeneer Y, Eersels JL, Hanssens H, Debie P, Keyaerts M, Windhorst AD, van der Aa F, Lecocq Q, Breckpot K, Morgenstern A, Bruchertseifer F, Lahoutte T, Devoogdt N, D'Huyvetter M.
Puttemans J, et al. Among authors: debie p.
Cancers (Basel). 2020 Apr 21;12(4):1017. doi: 10.3390/cancers12041017.
Cancers (Basel). 2020.
PMID: 32326199
Free PMC article.